Showing 1 - 10 of 86
Persistent link: https://www.econbiz.de/10003543728
We update and extend our previous study of the effect of drug age -- years since FDA approval -- on total medical expenditure, in several respects. The estimates indicate that, in the entire population, a reduction in the age of drugs utilized reduces non-drug expenditure 7.2 times as much as it...
Persistent link: https://www.econbiz.de/10013249231
Persistent link: https://www.econbiz.de/10011964261
Persistent link: https://www.econbiz.de/10010407486
I analyze the effects of four types of medical innovation and cancer incidence on US cancer mortality rates during the … pre‐dated factors that drove both innovation and mortality and that there would have been parallel trends in mortality in … the absence of innovation, the estimates indicate that there were three major sources of the 13.8% decline of the age …
Persistent link: https://www.econbiz.de/10010466909
Persistent link: https://www.econbiz.de/10011701670
Persistent link: https://www.econbiz.de/10013556762
contribution by Lichtenberg (2004), which relates longevity in the United States to pharmaceutical innovation and public health …
Persistent link: https://www.econbiz.de/10008678138
Assessing the benefits of medical innovation—its impact on health outcomes—is as important as assessing the costs … that investigates the benefits and costs of another broad category of medical innovation—inpatient therapeutic procedure … innovation—using data on over one million hospital discharges. …
Persistent link: https://www.econbiz.de/10011042743
We investigate the impact of pharmaceutical innovation on longevity, hospitalization and medical expenditure in Turkey …
Persistent link: https://www.econbiz.de/10011048363